In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Shin-ichi Kano
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Shin-ichi Kano

RESEARCHER INFORMATION
Country/Territory:U.S.A.
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 15 July 2013]
View all comments by Shin-ichi Kano
Clinical Interests:
Bipolar disorder , Drug abuse, Depression, Schizophrenia, Neurodevelopmental disorders (e.g., 22q11 deletion syndromes), Anxiety disorders , Autism spectrum disorders (pervasive developmental disorders), Attention-deficit hyperactivity disorder (ADHD, ADD)
Research Focus:
Microscopy, Proteomics, Cell biology, Neurodevelopment, Pharmacology, Signal transduction, Animal models, DNA microrrays, Neurotransmission, Immunology, Neuropathology, Glutamatergic transmission, Molecular and Cell biology, Glia/myelin, Stem cells
Work Sector(s):
University
Web Sites:
Professional: http://www.hopkinsmedicine.org/Psychiatry/sawalab/
Top Papers
1: Kano S, Colantuoni C, Han F, Zhou Z, Yuan Q, Wilson A, Takayanagi Y, Lee Y, Rapoport J, Eaton W, Cascella N, Ji H, Goldman D, Sawa A
Genome-wide profiling of multiple histone methylations in olfactory cells: further implications for cellular susceptibility to oxidative stress in schizophrenia.
Mol Psychiatry. 2013 Jul;18(7):740-2.
PMID: 22925834

2: Niwa M, Jaaro-Peled H, Tankou S, Seshadri S, Hikida T, Matsumoto Y, Cascella NG, Kano S, Ozaki N, Nabeshima T, Sawa A.
Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids.
Science. 2013 Jan 18;339(6117):335-9.
PMID: 23329051

3: Kano S, Nwulia E, Niwa M, Chen Y, Sawa A, Cascella N.
Altered MHC class I expression in dorsolateral prefrontal cortex of nonsmoker patients with schizophrenia.
Neurosci Res. 2011 Nov;71(3):289-93.
PMID: 21801761

4: Kano S, Sato K, Morishita Y, Vollstedt S, Kim S, Bishop K, Honda K, Kubo M, Taniguchi T.
The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells.
Nat Immunol. 2008 Jan;9(1):34-41. Epub 2007 Dec 2.
PMID: 18059273



Research Participants
Collaborators
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright